Skip to content

The development of a method for prediction of future glucose values using additional vital body signs.

The development of a method for prediction of future glucose values using additional vital body signs. - glucose prediction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31558
Enrollment
20
Registered
2008-03-11
Start date
2008-06-24
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

None listed

Sponsors

Máxima Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Subject uses insulin pump paradigm 512/712, 515/ 715 or real time 2. Type 1 diabetes mellitus * 1 year 3. Age * 18 years 4. BMI

Exclusion criteria

Exclusion criteria: 1. Women of childbearing potential who are pregnant, breast-feeding or intend to become pregnant within the next 26 weeks or are not using adequate contraceptive methods (adequate contraceptive measures as required by local law or practice). (Adequate contraceptive measures are defined as sterilization, intra-uterine device, oral contraceptives or consistent use of barrier methods) 2. Active proliferative retinopathy or maculopathy requiring treatment within 6 months prior to screening. 3. Cardiac disease defined as NYHA class III or IV, unstable angina and/or myocardial infarction within 6 months prior to screening. 4.Uncontrolled hypertension (treated or untreated) as judged by the Investigator 5. Any disease or condition (such as renal, hepatic or cardiac) that according to the judgment of the investigator makes the subject unsuitable for participation in the trial. 6. Use of concomitant medication which may alter glucose metabolism including but not limited to: systemic (or inhaled) glucocorticoids or non-selective beta-blockers. 7. Substance abuse including abuse of anabolic steroids. 8. Mental incapacity or language barrier precluding adequate understanding and/or cooperation.

Design outcomes

Primary

MeasureTime frame
·Glucose · Physical activity · ECG · Temperature · Breathing rate · Emotional stress . Food intake · Insulin dosage · Other medication · Age · Gender · Height · Weight · Time since diagnose · HbA1C · Type of medication · Type of insulin

Secondary

MeasureTime frame
.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)